FARMACEUTICALRX today announced it has been issued a medical marijuana dispensary license under Act 63 of 2023. This license grants the company the right to open three medical marijuana dispensaries in Pennsylvania. The company was also granted a permit to operate the first of its three medical marijuana dispensaries in the Oakland neighborhood of Pittsburgh. The dispensary license, together with the company's existing grower/processor license and operations, now position it to become a full vertically integrated operator in Pennsylvania.
"We are excited to open our medical marijuana dispensaries in Pennsylvania," said Rebecca Myers, founder and CEO of FARMACEUTICALRX. "We are the sole organic cultivator in the Pennsylvania market, and we are thrilled to soon provide a great retail experience for patients and to offer specialty craft, best-in-class, and organic products to our Pennsylvania patients. Our organic, specialty craft cannabis differentiation, together with the momentum associated with federal rescheduling and with the possible passage of an adult use program in Pennsylvania provide exciting potential further upsides for our business. This critical step positions us to expand sales through our own dispensaries and to continue to build our FARMACEUTICALRX brand together with our suite of sub-branded products to maximize value for our shareholders during this critical time."
